The federal government only pays 17% of Puerto Rico’s Medicaid costs to begin with, compared to 70% for the states, so further cuts will devastate the Island even more
The fall from grace last week of Dr. José Baselga, the former chief scientific officer of Memorial Sloan Kettering Cancer Center, illuminated a longstanding problem of modern medicine: Potentially corrupting payments by drug and medical device makers to influential people at research hospitals are far more common than either side publicly acknowledges.
The history of the fight for single-payer health care for the elderly and poor should inform today’s movement to win for Medicare for All.
The burst of state activity on drug costs recalls the way states acted on their own to pass laws to expand health insurance coverage in the years before Congress passed the Affordable Care Act in 2010
In this column for Tarbell, Wendell Potter describes how corporate health care interests sow “fear, uncertainty and doubt,” referred to by insiders as a “FUD campaign,” to scare the public from supporting anything that undermines their profits.
Two issues – protections for people with pre-existing conditions and drug prices – have unique bipartisan traction